RS Research
Company Details
Status: Private
Employees: 11-50
Location:
Teknopark Istanbul, Sanayi Mah. Teknopark Blv., No:1/2A 401, Istanbul, Pendik 34912, TR
Type:
sample
sample
Technology:
sample
About: RS Research is a clinical-stage biotechnology start-up based in Epalinges, Switzerland, with an additional location in Istanbul, Turkey. Founded in 2015, the company specializes in discovering and developing smart nanomedicines aimed at targeted cancer therapy.
The company provides services for pre-clinical studies, utilizing its expertise in innovative drug delivery platforms to support the development of nanomedicines. RS Research's product pipeline includes smart nanomedicines like Sagitta® and Dui, which enhance the therapeutic index and manufacturability of treatments, and RS-0139, a drug candidate currently in Phase I clinical trials that targets tumors with specific receptors.
RS Research is committed to advancing its technologies through research and development, as evidenced by its presentations at international conferences. The leadership team includes Co-Founder and Chief Scientific Officer Rana Sanyal and Co-Founder and Chief Operating Officer Sena Nomak.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
RS Research | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.